Oncogenic protein-tyrosine kinases may induce abnormal growth by stimulating signal transduction pathways involved in regulating cell proliferation by growth factor receptors. Research proposed here is concerned with potential signalling pathways that mediate oncogenesis by the viral Src tyrosine kinase encoded In Rous sarcoma virus. GTPase-activating protein (GAP), which regulates the activities of Ras proteins, has been implicated in mitogenic signalling by growth factor receptors and oncogenic tyrosine kinases. Our recent studies suggest that the viral and cellular Src kinases associate with and phosphorylate GAP in a complex. Experiments are proposed herein to explore further the role of GAP in oncogenesis by the viral Src kinase. Complementary genetic and biochemical studies will investigate how activated Src may regulate GAP through either direct or indirect mechanisms. These studies will: i) characterize the protein components that associate with GAP in complexes which may be essential for the regulation or function of GAP In Src oncogenesis; ii) determine the molecular features of GAP that are involved in interactions with Src and other GAP-associated proteins; iii) examine the in vivo phosphorylation state of GAP and its associated proteins to determine whether these correlate with the activation of cellular Ras; and iv) evaluate whether GAP has an indispensable role in Src oncogenesis by using antisense GAP nucleic acids to block expression of GAP in Src transformed cells. Together, experiments proposed in this application will provide new information on how interactions among protein components of GAP complexes might contribute to Src oncogenesis and point the way toward new avenues of investigation. Greater understanding of how activated Src subverts mitogenic signal transduction pathways will suggest possible targets for therapeutic Intervention in human cancers induced by oncogenic tyrosine kinases.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA055652-04
Application #
2096769
Study Section
Experimental Virology Study Section (EVR)
Project Start
1992-07-16
Project End
1995-08-31
Budget Start
1995-05-01
Budget End
1995-08-31
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Scuto, A; Kirschbaum, M; Buettner, R et al. (2013) SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-?B/STAT3 complex to its promoter in malignant lymphoid cells. Cell Death Dis 4:e635
Ma, Yuelong; Kowolik, Claudia M; Swiderski, Piotr M et al. (2011) Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA. ACS Chem Biol 6:962-70
Scuto, A; Krejci, P; Popplewell, L et al. (2011) The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival. Leukemia 25:538-50
Scuto, Anna; Kujawski, Maciej; Kowolik, Claudia et al. (2011) STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma. Cancer Res 71:3182-8
Buettner, Ralf; Mesa, Tania; Vultur, Adina et al. (2008) Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells. Mol Cancer Res 6:1766-74
Vultur, Adina; Buettner, Ralf; Kowolik, Claudia et al. (2008) SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. Mol Cancer Ther 7:1185-94
Scuto, Anna; Kirschbaum, Mark; Kowolik, Claudia et al. (2008) The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells. Blood 111:5093-100
Scuto, Anna; Zhang, Hongling; Zhao, Haiyan et al. (2007) RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase. Cancer Res 67:10317-24
Buettner, Ralf; Huang, Mei; Gritsko, Tanya et al. (2007) Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity. Mol Cancer Res 5:823-32
Nam, Sangkil; Williams, Ann; Vultur, Adina et al. (2007) Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells. Mol Cancer Ther 6:1400-5

Showing the most recent 10 out of 69 publications